BCYC Q2 2021 Earnings — Bicycle Therapeutics plc Revenue & Financial Results | Market Cap Arena

BCYCBicycle Therapeutics plc

$360M

Q2 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$2M+13.6% YoY

Gross Profit

$2M100.0% margin

Operating Income

-$17M-967.9% margin

Net Income

-$18M-1003.5% margin

EPS (Diluted)

$-0.74

QoQ Revenue Growth

-1.3%

Cash Flow

Operating Cash Flow

-$12M

Free Cash Flow

-$13M

Stock-Based Comp.

$3M

Balance Sheet

Total Assets

$226M

Total Liabilities

$84M

Stockholders' Equity

$142M

Cash & Equivalents

$199M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2M	$2M	+13.6%
Gross Profit	$2M	$2M	+13.6%
Operating Income	-$17M	-$13M	-37.3%
Net Income	-$18M	-$12M	-47.9%